Matthew Rizzo, Director, 10% Owner at Xtant Medical Holdings, Inc. (XTNT), bought 9,923,568 shares at $7.20 ($71.4M) on 2018-02-14, disclosed to the SEC on 2018-02-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.20 | 342,132 | $2.5M | 3.4% |
| 2 | $7.20 | 342,132 | $2.5M | 3.4% |
| 3 | $7.20 | 603,687 | $4.3M | 6.1% |
| 4 | $7.20 | 603,687 | $4.3M | 6.1% |
| 5 | $7.20 | 2,905,396 | $20.9M | 29.3% |
| 6 | $7.20 | 5,126,534 |
| $36.9M |
| 51.7% |
| Total | $7.20 avg | 9,923,568 | $71.4M | 100% |